BIOSU
Closed
Bioplus Acquisition Corp Unit
10.8
0.0 (0.00%)
Last Update: 13 Oct 2023 16:30:00
Yesterday: 10.8
Day's Range: 10.8 - 10.8
Send
sign up or login to leave a comment!
When Written:
10.48
BioPlus Acquisition Corp Unit is a special purpose acquisition company (SPAC) that was formed in 2021 for the purpose of merging with one or more businesses in the biotechnology and life sciences industries. The company is listed on the NASDAQ stock exchange under the ticker symbol "BPMC.U".
BioPlus Acquisition Corp Unit raised $200 million in its initial public offering (IPO) in March 2021. The company is led by CEO and Chairman Dr. Frank Torti, a former Chief Scientific Officer at Roche Pharmaceuticals.
As a SPAC, BioPlus Acquisition Corp Unit has a limited time frame to identify and complete a merger with a target company. If the company is unable to complete a merger within a certain time period, it will be required to return the funds raised in its IPO to its investors.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
BioPlus Acquisition Corp Unit raised $200 million in its initial public offering (IPO) in March 2021. The company is led by CEO and Chairman Dr. Frank Torti, a former Chief Scientific Officer at Roche Pharmaceuticals.
As a SPAC, BioPlus Acquisition Corp Unit has a limited time frame to identify and complete a merger with a target company. If the company is unable to complete a merger within a certain time period, it will be required to return the funds raised in its IPO to its investors.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








